Trials / Withdrawn
WithdrawnNCT03255330
The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Masaryk University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Study of the effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin | Gabapentin will be given approximately 3 months until no chronic neuropathic pain is present |
| DRUG | Metamizol | Standardized treatment |
| DRUG | Tramadol | Standardized treatment |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2020-02-01
- Completion
- 2020-08-01
- First posted
- 2017-08-21
- Last updated
- 2019-03-07
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT03255330. Inclusion in this directory is not an endorsement.